Robert Brooks

Aurora Biopharma, Inc. develops Chimeric Antigen Receptor (CAR) T therapy, cancer vaccines, and combinations with checkpoint Inhibitors services. It develops Aurora’s “Bionic” T Cells : CAR T-Cells engineered to kill cancer and Aurora’s Revolutionary CAR T cell Clinical Cancer Trials. The company was founded by Robert Brooks and Marc Lippman and is headquartered in Cambridge, MA.

Alphageneron Pharmaceuticals, Inc. is a biotechnology company that specializes in developing antibody drug conjugates and natural killer. The company is based in Cambridge, MA. The company was founded by Robert K. Brooks and he has been the CEO since incorporation.

Aurora Biopharma, Inc. develops Chimeric Antigen Receptor (CAR) T therapy, cancer vaccines, and combinations with checkpoint Inhibitors services. It develops Aurora’s “Bionic” T Cells : CAR T-Cells engineered to kill cancer and Aurora’s Revolutionary CAR T cell Clinical Cancer Trials. The company was founded by Robert Brooks and Marc Lippman and is headquartered in Cambridge, MA.

Alphageneron Pharmaceuticals, Inc. is a biotechnology company that specializes in developing antibody drug conjugates and natural killer. The company is based in Cambridge, MA. The company was founded by Robert K. Brooks and he has been the CEO since incorporation.

Alphageneron Pharmaceuticals, Inc. is a biotechnology company that specializes in developing antibody drug conjugates and natural killer. The company is based in Cambridge, MA. The company was founded by Robert K. Brooks and he has been the CEO since incorporation.